logo-loader
viewWalgreens Boots Alliance Inc

Walgreens Boots to acquire Rite Aid in $17.2bn deal

Walgreens Q4 profit beats estimates on increased prescriptions, cost cuts.

1-SG02055.jpg
Walgreens controls 31% and Rite Aid has 10% in the pharmacy and drug-store business.

Walgreens Boots Alliance (NASDAQ:WBA) agreed to acquire Rite Aid (NYSE:RAD)  in a $17.2 billion deal and reported profit that topped analysts’ estimates in its fourth quarter.

The deal would combine the second and third largest drug-store operators and would intensify the already tough competition with CVS Health.

CVS has 58% market share in the pharmacy and drug-store business, Walgreens controls 31% and Rite Aid has 10%.

Walgreens said in a statement on Tuesday that it is paying $9 per share in cash in a valuation that includes the assumption of debt. That reflects a 48% premium above Rite Aid's value at the close of trading Monday.

On Wednesday, Deerfield, Illinois-based Walgreens reported fiscal fourth-quarter earnings, Excluding one-time items, were $0.88 per share. That surpassed the $0.81 average of analysts’ estimates compiled by Capital IQ

Revenue totaled $28.5bn, equaling analysts’ estimates.

The company’s pharmacies filled 222mln prescriptions in the quarter, up 4.6 percent from a year before.

The drugstore chain said it has saved $799mln this fiscal year from cost cuts,

Shares of Walgreens fell 1.9% to $95.16 as of 8:32 in premarket trades in New York.

Quick facts: Walgreens Boots Alliance Inc

Price: 51.45 USD

NASDAQ:WBA
Market: NASDAQ
Market Cap: $45.58 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Co-Diagnostics expects to win a CE mark-validated...

Co-Diagnostics Inc (NASDAQ:CODX) CEO Dwight Egan tells Proactive the Utah-based company expects to achieve a CE mark validation on its coronavirus detection test from the European Union by as early as next week. Egan says the company is very enthused by the entire process of the development...

2 days, 10 hours ago

2 min read